CHESSER PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: H85021 | CARSHALTON, SM5 2RT
Showing results 451-500 of 503
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mercaptopurine | 13 | 525 | £236 | -16.0% ▼ |
| Iron and folic acid | 13 | 390 | £33 | +64.1% ▲ |
| Betamethasone sodium phosphate | 13 | 130 | £30 | +95.2% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 13 | 13 | £183 | -88.5% ▼ |
| 13 | 164 | £1.4K | -26.0% ▼ | |
| 13 | 600 | £1.7K | -12.1% ▼ | |
| 13 | 480 | £1.3K | +37.7% ▲ | |
| Ipratropium bromide | 12 | 15 | £79 | -58.3% ▼ |
| Formoterol/glycopyrronium/budesonide | 12 | 12 | £507 | -80.1% ▼ |
| Dexamfetamine sulfate | 12 | 1,752 | £1.4K | -66.6% ▼ |
| Fentanyl | 12 | 120 | £291 | -88.3% ▼ |
| Eslicarbazepine acetate | 12 | 360 | £871 | -46.2% ▼ |
| Ropinirole hydrochloride | 12 | 84 | £24 | -88.7% ▼ |
| Metformin hydrochloride/sitagliptin | 12 | 672 | £111 | -67.9% ▼ |
| Repaglinide | 12 | 1,080 | £101 | -50.4% ▼ |
| Indoramin | 12 | 720 | £600 | -21.1% ▼ |
| Sodium feredetate | 12 | 6,000 | £171 | -58.1% ▼ |
| Powder extensively hydrolysed formula (0913101) | 12 | 22.8K | £628 | -83.3% ▼ |
| Betamethasone sodium phosphate | 12 | 130 | £29 | -53.7% ▼ |
| Cocois | 12 | 1,200 | £165 | -12.6% ▼ |
| Pimecrolimus | 12 | 360 | £225 | -29.1% ▼ |
| 12 | 1,400 | £37 | -7.0% ▼ | |
| 12 | 3,780 | £5.6K | -34.8% ▼ | |
| 12 | 75 | £208 | -50.4% ▼ | |
| 12 | 1,250 | £178 | -69.2% ▼ | |
| 12 | 360 | £1.8K | +3.3% ▲ | |
| 12 | 850 | £3.2K | -73.5% ▼ | |
| 12 | 420 | £928 | -15.2% ▼ | |
| Rabeprazole sodium | 11 | 616 | £51 | -78.7% ▼ |
| Telmisartan with diuretic | 11 | 308 | £89 | -2.7% ▼ |
| Dabigatran etexilate | 11 | 616 | £499 | -78.8% ▼ |
| Oxcarbazepine | 11 | 990 | £159 | -60.7% ▼ |
| Biphasic isophane insulin | 11 | 110 | £478 | -90.1% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 11 | 184.8K | £2.1K | -41.2% ▼ |
| Other eye tear/lubricant/astringent preparations | 11 | 1,600 | £121 | +0.6% vs avg |
| Aluminium chloride | 11 | 480 | £107 | +35.7% ▲ |
| 11 | 110 | £219 | +0.5% vs avg | |
| 11 | 110 | £267 | +2.6% ▲ | |
| 11 | 80 | £309 | -72.4% ▼ | |
| 11 | 36 | £138 | -64.5% ▼ | |
| 11 | 20 | £2.7K | -69.2% ▼ | |
| 11 | 90 | £295 | -46.4% ▼ | |
| Aluminium and magnesium and activated simeticone | 10 | 6,000 | £88 | +167.5% ▲ |
| Codeine phosphate | 10 | 2,600 | £93 | -30.3% ▼ |
| Zuclopenthixol decanoate | 10 | 95 | £386 | -37.7% ▼ |
| Domperidone | 10 | 478 | £10 | -72.0% ▼ |
| Opicapone | 10 | 300 | £590 | -47.8% ▼ |
| Glimepiride | 10 | 300 | £11 | -89.2% ▼ |
| Azelaic acid | 10 | 300 | £43 | -58.2% ▼ |
| Salicylic acid | 10 | 100 | £33 | -20.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.